1[1]Konopleva M, Tari A M, Estrov Z, et al.Liposomal Bcl-2 antisense oligonucleotides enhance proliferation, sensitize acute myeloid leukemia to cytosine-arabinoside, and induce apoptosis independent of other antiapoptotic proteins[J]. Blood, 2000 ,95(12):3929-3938.
2[2]Wickstrom E L, Bacon T A, Gonzalez A, et al. Anti-c-myc DNA increases differentiation and decreases colony formation by HL-60 cells[J]. In Vitro Cell Dev Biol,1989,25(3 Pt 1):297-302.
3[3]McGahon A, Bissonnette R, Schmitt M, et al.BCR-ABL maintains resistance of chronic myelogenous leukemia cells to apoptotic cell death[J].Blood, 1994,83(5):1179-1187.
4[4]Skorski T, Nieborowska-Skorska M, Barletta C, et al.Highly efficient elimination of Philadelphia leukemic cells by exposure to bcr/abl antisense oligodeoxynucleotides combined with mafosfamide[J]. J Clin Invest,1993, 92(1):194-202.
5[5]Vasanthakumar G, Ahmed N K. Modulation of drug resistance in a daunorubicin resistant subline with oligonucleoside methylphosphonates[J]. CancerCommun,1989,1(4):225-232.
6[6]Pace U, Bockman J M, Mackay B J,et al. A ribozyme which discriminates in vitro between PML/RAR alpha, the t(15; 17)-associated fusion RNA of acute promyelotic leukemia, and PML and RAR alpha, the transcripts from the nonrearranged alleles[J]. Cancer Res, 1994, 54(24): 6365-6369.
7[7]Wright L, Wilson S B, Milliken S, et al. Ribozyme-mediated cleavage of bcr-abl transcript expressed in chronic myeloid leukemia[J]. Exp Hematol, 1993, 21(13):1714-1718.
8[8]Bertram J, Palfner K, Killian M, et al. Reversal of multiple drug resistance in vitro by phosphorothioate oligonucleotides and ribozymes[J].Anticancer Drugs, 1995, 6(1): 124-134.
9[9]Jiang C Y,Mao N,Zhang M M,et al.Human IL-2 gene transfer increase the sensitivity of myeloid leukemia cells to cytotoxicity of LAK cells[J].Exp Haematol, 1993,21(8):1157.
10[10]Weber J S,Rosenberg S A.Effect of murine tumor class I activity of tumor-infiltrating lymphocytes[J].J Natl Cancer Inst,1990,57(2):149-156.
